Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5747061A · kind A · utility
76Cited by
10References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 1996 |
| Grant date | May 5, 1998 |
| Priority date | — |
| Expiry date | Jul 29, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel compositions of matter for delivering water-insoluble steroid drugs suitable for therapeutic use. The invention also provides stable aqueous suspensions of water-insoluble steroid drugs of particle sizes of .ltoreq.30 .mu.m which remain in such a state so as to allow for immediate suspension, when desired, even after extended periods of settling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.